Access cutting-edge myelofibrosis treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.
Access myelofibrosis specialists in Durham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myelofibrosis treatment provided free
The main purpose of this study with corresponding optional expansion is to evaluate the efficacy of selinexor in JAKi-naïve participants with myelofibrosis (MF) and moderate thrombocytopenia based on spleen volume reduction (SVR). Additional efficacy and safety parameters will also be assessed during the study.
Sponsor: Karyopharm Therapeutics Inc
Check if you qualify for this myelofibrosis clinical trial in Durham, NC
If you're searching for myelofibrosis treatment options in Durham, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myelofibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.